PwC Moldova: Tax and Legal Alert no. 9/2015: New rules on medicine price formation

  • 07.09.2015

 The Law regulating pharmaceutical activity has been amended to include new rules on medicine price formation.

In detail. Under the amendments, as of 1 October 2015 the 15% profitability requirement is removed from the delivery price of medicines manufactured by domestic producers. 
A new mechanism has been established on the mark-up of medicines. The mark-up rates vary with the prices registered in the National catalogue of manufacturers’ prices for medicines. To this aim, medicines and other pharmaceutical products have been classified into five categories, according to their prices, with the following mark-up thresholds applicable to the delivery / acquisition price.

Read the full version in English and Romanian.

PricewaterhouseCoopers (PwC) Moldova
PricewaterhouseCoopers (PwC) Moldova

PwC helps organisations and individuals create the value they’re looking for. We’re a network of firms in 157 countries with more than 208,000 people who are committed to delivering quality in assurance, tax and advisory services. This network structure provides PwC member firms with the flexibility to operate simultaneously as local businesses, but also on a global scale, creating a platform through which member firms share knowledge, skills and resources and delivery services of consistently high quality to international and local clients. PwC started operations in Moldova in 1996. It has continuously expanded the scope of its services and currently offers a full range of professional services to both international and Moldovan enterprises. Overseen by 16 partners and employing over 600 specialists and support staff, PwC operates in Romania and Moldova from a network of four offices in Bucharest, Timisoara, Cluj-Napoca, Constanta and Chisinau.

Latest Members & Partners News